Top Banner
47
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Role of MRIversus US in placental abnormalities and diseases
Page 2: Role of MRIversus US in placental abnormalities and diseases

ROLE OF MRI VERSUS ULTRASOUND IN THE

ASSESSMENT OF PLACENTAL ABNORMALITIES AND

DISEASES

2015

Page 3: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1

The placenta is often overlooked in the routineevaluation of a normal gestation, receiving attentiononly when an abnormality is detected

Although uncommon, abnormalities of theplacenta are important to recognize owing to thepotential for maternal and fetal morbidity andmortality

Page 4: Role of MRIversus US in placental abnormalities and diseases

Background1

Placental abnormalities and diseases include:1. Abnormal location (Placenta previa)2. Abnormal implantation (PAD)3. Degenerative and vascular abnormalities (Vasa

previa, placental abruption, hematomas,placental bed infarction)

4. Abnormal placental thickness/size (volume)5. Abnormal placental shapes (normal variants)6. Placental calcifications7. Placental tumors (GTD, nontrophoblastic

placental tumors, metastases, cystic lesions)8. Placenta in multiple gestations

Page 5: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1Placenta

Previa

Low-lying Marginal Complete Central

Page 6: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1

PLACENTAL INVASION

Page 7: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1

•Placenta Accreta occurs when a defectof the decidua basalis allows the invasion ofthe chorionic villi into the myometrium.

•Classification:

Page 8: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1

Risk Factors for PA

Placenta Previa

Catastrophic intrapartum

heamorrhage

Previous CS

Page 9: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1

Most Commonly

US

Recently MRI

• Depth of Invasion

• Posterior Placenta

• Equivocal US Results

Page 10: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1 US

Gray scale B-mode Transabdominal USColor Doppler US

Page 11: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1 MR

I

MRI Coronal T1 & Sagittal T2-weighted FSE

Page 12: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1Placenta previa findings that are considered suggestive of accreta/percreta on US :

1. Loss of the retroplacental hypoechoic clear zone

2. Loss of the bladder wall-uterine interface

3. Presence of placental lacunae (vascular spaces)

4. Presence of hypervascularity of the interface between the uterine serosa and the bladder wall on color Doppler imaging

Page 13: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1Placenta previa findings that are considered suggestive of accreta/percreta on MRI :

1. Uterine bulging2. Heterogeneous signal intensity within

the placenta3. Dark intraplacental bands on T2-WI4. Focal interruptions in the myometrial

wall5. Direct visualization of the invasion of

pelvic structures by placental tissue

Page 14: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1

GESTATIONAL TROPHOBLASTIC DISEASE

Page 15: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1

Gestational Trophoblastic Disease

BENIGN

Complete mole

Partial mole

MALIGNANT

Page 16: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1

Types of Gestational Trophoblastic

Disease

BENIGN

Complete mole

Partial mole

MALIGNANT

Invasive mole

Choriocarcinoma

Page 17: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1

PLACENTAL ABRUPTION & HEMATOMA

Page 18: Role of MRIversus US in placental abnormalities and diseases

PLACENTAL ABRUPTION & HEMATOMA1

ACUTESUBACUTE3-14 days

Hyper to isoechoic

Hypoechoic anechoic

Poor sonographic detection:1. Echotexture of acute hemorrhage is very similar to that of the adjacent placenta

2. Abnormally thick and heterogeneous placenta is only present in large acute clots

3. Subacute clots may not be visualized because blood dissects out and drains through the cervix

SUBACUTE>14 days

Placental abruption is a condition in which the placenta

peels away from the uterine wall partially or almost

completely before delivery. It is mainly a clinical

diagnosis and is only seen on ultrasound when

associated with a haematoma or increasedheterogeneous placental thickness

Page 19: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1MRI can accurately diagnose placental abruption, and

should be considered after negative US findings. It

offers a higher soft tissue contrast and the ability to

depict blood and help differentiate it from other fluidcollections.

We rely on T1 and T2WIs for tissue characterization, with special referenceto the paramagnetic effects of methemoglobin, it is possible to estimate theage of bleeding

Page 20: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1

Page 21: Role of MRIversus US in placental abnormalities and diseases

Background & Aim of Work1

The aim of this work was to high lightenthe role of (MRI) in detecting placentalabnormalities and diseasesSoha Talaat Hamed *, Ahmed Mahmood H* * , Lamia Muhammed Bassam **radiology department ,** obstetric & gynecology department

Page 22: Role of MRIversus US in placental abnormalities and diseases

Patients and methods2

Fifty pregnant females with placentalabnormalities and diseases had beenevaluated; we divided them into 3 groups:Group I: (40/50) Abnormal placental locationand/or implantation (one ectopic pregnancy onCS scar with decidual invasion and 39 placentaprevia at high risk of coexisting PAD)Group II: (8/50) Gestational trophoblasticdiseaseGroup III: (2/50) Placental hematoma andabruption

Page 23: Role of MRIversus US in placental abnormalities and diseases

Patients and methods2

Ultrasound examination was performed using:

•LOGIQ 7 PRO, GE (General Electric Medical System)

Transabdominal approachfor all cases using 5 MHzsector transducerTransvaginal and/ortranslabial approach using7-8 MHz endoluminaltransducer

Page 24: Role of MRIversus US in placental abnormalities and diseases

Patients and methods2

Pelvic MRI was performed for all cases using a1.5-T (Gyroscan Intera, Philips medicalsystems, Netherland)

Protocol of scanning for group I and group III:1. T2WI FSE (axial, sagittal and coronal planes)2. T1WI SE (axial, sagittal and coronal planes)3. B-FFE (sagittal and coronal planes)

Protocol of scanning for group II:1. T2WI FSE (axial, sagittal and coronal planes)2. T1WI SE (axial, sagittal and coronal planes)3. T1WI SE post contrast (axial, sagittal and

coronal planes)

Page 25: Role of MRIversus US in placental abnormalities and diseases

Results3

80%(40/50)

16%

(8/50)

4%

(2/50)

Placental abnormalities & diseases

Abnormal placental location and/or implantation

Gestational trophoblastic diseases

Placental hematoma and abruption

Page 26: Role of MRIversus US in placental abnormalities and diseases

Results3

Group I: (39/50 patients with placenta previaat high risk for placenta accreta)These were the cases statistically evaluated inthis study

Page 27: Role of MRIversus US in placental abnormalities and diseases

Results3

58.97%

(23/39)

30.77%

(12/39)

5.15%(2/39)

5.15%

(2/39)

Subtypes of placenta previa

Central

Complete

Marginalis

Low lying

Page 28: Role of MRIversus US in placental abnormalities and diseases

Results3

Placenta Previa

Accreta No Accreta

Operat. & Path. 25 (64.1%) 14

Page 29: Role of MRIversus US in placental abnormalities and diseases

Results3

36%(9/25)

36%(9/25)

28%(7/25)

Types of placental invasion

Accreta

Percreta

Increta

Page 30: Role of MRIversus US in placental abnormalities and diseases

Results3

Sensitivity, Specificity, PPV and NPV of US diagnostic criteria

Item Sensitivity Specificity (+)ve PV (-)ve PV Accuracy

Loss of retroplacental

clear space68.00 85.71 89.47 60.00 74.36

Loss of bladder uterine

interface24.00 100.00 100.00 42.42 51.28

Vascular lacunae 56.00 92.86 93.33 54.17 69.23

Increased vascularity

on Ut.-bladder

interface

24.00 92.86 85.71 40.62 48.72

Dec. Myometrial

Thickness48.00 92.86 92.31 50.00 64.10

Page 31: Role of MRIversus US in placental abnormalities and diseases

Results3

Sensitivity, specificity, PPV and NPV of MRI diagnostic criteria

Items Sensitivity Specificity (+)ve PV (-)ve PV Accuracy

Heterogeneous

placenta intensity80.00 78.57 86.96 68.75 79.49

Dark intraplacental

bands on T272.00 92.86 94.74 65.00 79.49

Focal interruption in

myometrial wall64.00 92.86 94.12 59.09 74.36

Uterine bulging 48.00 100.00 100.00 51.85 66.67

Direct visualization of

invasion of pelvic

structures

24.00 100.00 100.00 42.42 51.28

Page 32: Role of MRIversus US in placental abnormalities and diseases

Results3

Item Sensitivity Specificity (+)ve PV (-)ve PV Accuracy

Final US 68.00 78.57 85.00 57.89 71.79

Final MRI 80.00 85.71 90.91 70.59 82.05

Page 33: Role of MRIversus US in placental abnormalities and diseases

Results3

Group I: (1/50 case of ectopic pregnancy on CS scarwith decidual invasion)That case was diagnosed by both modalitieshowever, decidual invasion was suggested by MRIGroup II: (8/50 cases GTD)1/8 was misdiagnosed by US as vesicular molehowever MRI revealed the myometrial invasion inthat choriocarcinoma/invasive mole caseGroup III: (2/50 cases hematoma/abruption)1/2 was suspected to by a placental mass by US,however MRI by its high sensitivity and specificity todetect different ages of blood helped to correctlydiagnose hematoma and abruption

Page 34: Role of MRIversus US in placental abnormalities and diseases

•A 26-year old pregnant female •GA 30 weeks, previous 2 CS 4

Case 1

Trans abdominal US gray scale and color Doppler

US

Trans labial US color Doppler

Page 35: Role of MRIversus US in placental abnormalities and diseases

Cases4Case 1

Sagittal and Coronal T2WI FSE

MR

I

Sagittal T1WI FSE

Page 36: Role of MRIversus US in placental abnormalities and diseases

Cases4Case 1

Placenta Increta & hysterectomy was done

Operative & Pathological Findings

Page 37: Role of MRIversus US in placental abnormalities and diseases

•A 32-year old pregnant female•GA 34 weeks, previous 2CS 4

Case 2

US

Transabdominal US gray scale & color Doppler

Page 38: Role of MRIversus US in placental abnormalities and diseases

Cases4Case 2

MR

I

Sagittal T2WI FSECoronal T1WI FSE

Page 39: Role of MRIversus US in placental abnormalities and diseases

Cases4Case 2

Placenta percreta & hysterectomy was done

Operative & Pathological Findings

Page 40: Role of MRIversus US in placental abnormalities and diseases

A 25 year-old female patient, history of complete abortion followed by repeated D&C4

Placental site tumour

MR

I

Sagittal T2 and T1WI FSESagittal T2 & post contrast T1WI FSE

Page 41: Role of MRIversus US in placental abnormalities and diseases

Case of invasive molar pregnancy 4Follow up after chemotherapy

Page 42: Role of MRIversus US in placental abnormalities and diseases

•A 26-year old pregnant female•Gestational age 15 weeks 4

Case

Trans abdominal color DopplerTrans abdominal 3D

US

Page 43: Role of MRIversus US in placental abnormalities and diseases

Cases4Case 10

Sagittal T2 and T1WI FSE

MR

I

Page 44: Role of MRIversus US in placental abnormalities and diseases

Discussion5Some studies concluded that MRI is anexcellent tool for staging and topographicevaluation of PAD, while others stated that MRIis less reliable in differentiating betweendifferent degrees of placental invasion,especially between accreta vera and increta.

Among the true positive cases, USunderestimated 2 cases of percreta andoverestimated 1 case, on the other hand MRIunderestimated 2 cases. Both modalities failedto diagnose 1 case of percreta posteriorly.

Masselli et al, 2008Varghese et al, 2013

Page 45: Role of MRIversus US in placental abnormalities and diseases

Discussion5

Matching between US and MRI findings tookplace in 78.57% (11/14) of the negative casesand in 68% (17/25) of the positive cases ofinvasion.

When US and MRI diagnosis is not matching, itis probably better to consider that the moreaggressive findings are correct.

Page 46: Role of MRIversus US in placental abnormalities and diseases

Take home message6

•MRI hand in hand with US is important for theaccurate diagnosis of placental abnormalities anddiseases especially the invasive placental processes(GTD and placenta previa/accreta).•Co-operation of both modalities may provide morediagnostic information.

US remains the first imaging modality of evaluation ofthe placenta.

Page 47: Role of MRIversus US in placental abnormalities and diseases

Thanks